摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

[Me2(P(O-i-Pr)3)Pt(μ-bis(diphenylphosphino)methane)Pt(P(O-i-Pr)3)Me2] | 850644-35-8

中文名称
——
中文别名
——
英文名称
[Me2(P(O-i-Pr)3)Pt(μ-bis(diphenylphosphino)methane)Pt(P(O-i-Pr)3)Me2]
英文别名
cis,cis-[Me2(P(O(i)Pr)3)Pt(μ-dppm)Pt(P(O(i)Pr)3)Me2];cis,cis-[Me2(P(O(i)Pr)3)Pt(μ-bis(diphenylphosphino)methane)Pt(P(O(i)Pr)3)Me2]
[Me2(P(O-i-Pr)3)Pt(μ-bis(diphenylphosphino)methane)Pt(P(O-i-Pr)3)Me2]化学式
CAS
850644-35-8
化学式
C47H76O6P4Pt2
mdl
——
分子量
1251.17
InChiKey
OABRQECYNMUDSD-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    None
  • 重原子数:
    None
  • 可旋转键数:
    None
  • 环数:
    None
  • sp3杂化的碳原子比例:
    None
  • 拓扑面积:
    None
  • 氢给体数:
    None
  • 氢受体数:
    None

反应信息

  • 作为产物:
    参考文献:
    名称:
    双核有机铂(II)配合物上的配体取代反应
    摘要:
    在双核dimethylplatinum(II)配合物式的N-供体配体的配位体取代反应顺,顺[我- 2的Pt(μ-NN)(μ-DPPM)PTME 2 ],1,其中DPPM =双(通过不同的亲核磷供体L,L = P(O– i Pr)3或PPh 3和L 2  = dppm,形成二核配合物2,顺式,顺式-[Me 2 LPt] (μ-dppm)PtLMe 2 ]和顺式,顺-[Me 2 Pt(μ-dppm)分别研究了2 PtMe 2 ]。配合物1在可见光区域具有MLCT带,该MLCT带用于容易地追踪其配体取代反应的动力学。这些反应涉及含有顺铂-碳键的二铂(II)配合物1,是通过正常的缔合机理进行的。如预期的那样,在本研究的缔合反应中,反应速率取决于进入组的浓度和性质。PPh 3的亲核性强于P(O– i Pr)3基于其更强的σ供体能力和较低的溶剂化,并且是观察到的其速率与P(O– i Pr)3相比提高了
    DOI:
    10.1016/j.jorganchem.2007.01.007
点击查看最新优质反应信息

文献信息

  • Binuclear dimethylplatinum (II) complexes each containing monodentate phosphine ligands and a bridging diphosphine ligand X(PPh2)2, X=CH2 or NH. Molecular structure of cis,cis-[Me2(pyPh2P)Pt(μ-Ph2PNHPPh2)Pt(PPh2py) Me2]·2CH2Cl2
    作者:Mehdi Rashidi、Katayoon Kamali、Michael C. Jennings、Richard J. Puddephatt
    DOI:10.1016/j.jorganchem.2005.01.002
    日期:2005.3
    bridging SMe2 ligand in the organodiplatinum(II) complexes cis,cis-[Me2Pt(μ-SMe2)μ-X(PPh2)2}PtMe2], in which X(PPh2)2 is either bis(diphenylphosphino)amine [dppa (X = NH)], 1a, or bis(diphenylphosphino)methane [dppm (X = CH2)], 1b, with 2 equiv of some monodentate phosphine ligands, L, gave a series of organodiplatinum(II) complexes with general formula cis,cis-[Me2LPt(μ-dppa)PtLMe2][L = PPh3, 2a, PPh2p
    不稳定桥接中小企业位移2在organodiplatinum(II)络合物配位体的顺式,顺式- [我2的PT(μ-SMe的2)μ-X(PPH 2)2 } PTME 2 ],其中X(PPH 2)2是双(二苯基膦基)胺[dppa(X = NH)] 1a或双(二苯基膦基甲烷[DPPM(X = CH 2)] 1b,具有2当量的一些单齿膦配体L,系列具有顺式,顺式-[Me 2 LPT(μ-dppa)PTLMe 2的有机二(II)配合物] [L = PPH 3,图2a,PPH 2 PY(2- diphenylphosphinopyridine,PN),3A,或P(O-我PR)3,图4a ]或顺式,顺式- [我2 LPT(μ-DPPMPTLMe 2 ] [L = PPH 3,2b中,PN,3B,或P(O-我PR)3,图4b ]以良好产率。在这些络合物中,两个属中心仅通过一个桥接的二膦配体结合在一起,而没有属-属键。当L为PPh
  • Organoplatinum(II) complexes with phosphite ligands
    作者:Ahmad R. Esmaeilbeig、Hamid R. Samouei、Mehdi Rashidi
    DOI:10.1016/j.jorganchem.2008.04.034
    日期:2008.7
    The phosphite complexes cis-[PtMe2L(SMe2)] in which L = P((OPr)-Pr-i)(3), 1a, or L = P(OPh)(3), 1b, were synthesized by the reaction of cis, cis-[Me2Pt(mu-SMe2)(2)PtMe2] with 2 equiv. of L. If 4 equiv. of L was used the bis-phosphite complexes cis-[PtMe2L2] in which L = P((OPr)-Pr-i)(3), 2a, or L = P(OPh)(3), 2b, were obtained. The reaction of cis-[Pt(p-MeC6H4)(2)(SMe2)(2) ] with 2 equiv. of L gave the aryl bis-phosphite complexes cis[ Pt(p-MeC6H4)(2)L-2] in which L = P((OPr)-Pr-i)(3), 2a', or L = P(OPh)(3), 2b'. Use of 1 equiv. of L in the latter reaction gave the bis-phosphite complex along with the starting complex in a 1:1 ratio.The complexes failed to react with MeI. The reaction of cis, cis-[Me2Pt(mu-SMe2)(2)PtMe2] with 2 equiv. of the phosphine PPh3 gave cis-[PtMe2(PPh3)(2)] and cis-[PtMe2(PPh3)(SMe2)] along with unreacted starting material. Reaction of cis-[PtMe2L(SMe2)], 1a and 1b with the bidentate phosphine ligand bis(diphenylphosphino) methane, dppm = Ph2PCH2PPh2, gave [PtMe2(dppm)], 8, along with cis-[PtMe2L2], 2. The reaction of cis-[PtMe2L(SMe2)] with 1/ 2 equiv. of the bidentate N-donor ligand NN = 4,4'-bipyridine yielded the binuclear complexes [PtMe2L(mu-NN)PtMe2L] in which L = P((OPr)-Pr-i)(3), 3a, or L = P(OPh)(3), 3b. The complexes were fully characterized using multinuclear NMR (H-1, C-13, P-31, and Pt-195) spectroscopy. (C) 2008 Elsevier B.V. All rights reserved.
查看更多

同类化合物

(βS)-β-氨基-4-(4-羟基苯氧基)-3,5-二碘苯甲丙醇 (S,S)-邻甲苯基-DIPAMP (S)-(-)-7'-〔4(S)-(苄基)恶唑-2-基]-7-二(3,5-二-叔丁基苯基)膦基-2,2',3,3'-四氢-1,1-螺二氢茚 (S)-盐酸沙丁胺醇 (S)-3-(叔丁基)-4-(2,6-二甲氧基苯基)-2,3-二氢苯并[d][1,3]氧磷杂环戊二烯 (S)-2,2'-双[双(3,5-三氟甲基苯基)膦基]-4,4',6,6'-四甲氧基联苯 (S)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (R)富马酸托特罗定 (R)-(-)-盐酸尼古地平 (R)-(-)-4,12-双(二苯基膦基)[2.2]对环芳烷(1,5环辛二烯)铑(I)四氟硼酸盐 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[((6-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[(4-叔丁基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[(3-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-(+)-4,7-双(3,5-二-叔丁基苯基)膦基-7“-[(吡啶-2-基甲基)氨基]-2,2”,3,3'-四氢1,1'-螺二茚满 (R)-3-(叔丁基)-4-(2,6-二苯氧基苯基)-2,3-二氢苯并[d][1,3]氧杂磷杂环戊烯 (R)-2-[((二苯基膦基)甲基]吡咯烷 (R)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (N-(4-甲氧基苯基)-N-甲基-3-(1-哌啶基)丙-2-烯酰胺) (5-溴-2-羟基苯基)-4-氯苯甲酮 (5-溴-2-氯苯基)(4-羟基苯基)甲酮 (5-氧代-3-苯基-2,5-二氢-1,2,3,4-oxatriazol-3-鎓) (4S,5R)-4-甲基-5-苯基-1,2,3-氧代噻唑烷-2,2-二氧化物-3-羧酸叔丁酯 (4S,4''S)-2,2''-亚环戊基双[4,5-二氢-4-(苯甲基)恶唑] (4-溴苯基)-[2-氟-4-[6-[甲基(丙-2-烯基)氨基]己氧基]苯基]甲酮 (4-丁氧基苯甲基)三苯基溴化磷 (3aR,8aR)-(-)-4,4,8,8-四(3,5-二甲基苯基)四氢-2,2-二甲基-6-苯基-1,3-二氧戊环[4,5-e]二恶唑磷 (3aR,6aS)-5-氧代六氢环戊基[c]吡咯-2(1H)-羧酸酯 (2Z)-3-[[(4-氯苯基)氨基]-2-氰基丙烯酸乙酯 (2S,3S,5S)-5-(叔丁氧基甲酰氨基)-2-(N-5-噻唑基-甲氧羰基)氨基-1,6-二苯基-3-羟基己烷 (2S,2''S,3S,3''S)-3,3''-二叔丁基-4,4''-双(2,6-二甲氧基苯基)-2,2'',3,3''-四氢-2,2''-联苯并[d][1,3]氧杂磷杂戊环 (2S)-(-)-2-{[[[[3,5-双(氟代甲基)苯基]氨基]硫代甲基]氨基}-N-(二苯基甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[((1S,2S)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[[((1R,2R)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2-硝基苯基)磷酸三酰胺 (2,6-二氯苯基)乙酰氯 (2,3-二甲氧基-5-甲基苯基)硼酸 (1S,2S,3S,5S)-5-叠氮基-3-(苯基甲氧基)-2-[(苯基甲氧基)甲基]环戊醇 (1S,2S,3R,5R)-2-(苄氧基)甲基-6-氧杂双环[3.1.0]己-3-醇 (1-(4-氟苯基)环丙基)甲胺盐酸盐 (1-(3-溴苯基)环丁基)甲胺盐酸盐 (1-(2-氯苯基)环丁基)甲胺盐酸盐 (1-(2-氟苯基)环丙基)甲胺盐酸盐 (1-(2,6-二氟苯基)环丙基)甲胺盐酸盐 (-)-去甲基西布曲明 龙蒿油 龙胆酸钠 龙胆酸叔丁酯 龙胆酸 龙胆紫-d6 龙胆紫